Bio Essence Corp
Close on Oct 19, 2026
- Market cap
- $21.38M
- P/E (TTM)
- 10.5
- Dividend yield
- –
About Bio Essence
Pharmaceutical Preparations, SIC 2834
Bio Essence Corp. is an herbal health, diet, and nutrition company that provides herbal health, diet, and vitamin nutritional supplements. The company operates by selling health supplement products and offering original equipment manufacturing (OEM) and private-label services to corporate clients. Its offerings historically encompassed traditional Chinese medicines such as single herbs, granules, pills, and tablets, alongside dietary formulas and medical foods. Following corporate restructuring, the company manages its commercial activities directly and outsources manufacturing and OEM production. Its customer base includes corporate clients contracting for outsourced product development and manufacturing services.
The company operates from a leased executive office in Irvine, California, which serves as its corporate headquarters, and it does not own any real estate properties. Bio Essence conducts its ongoing operations within the United States with a full-time workforce of four employees. All commercial and outsourced operations are centrally directed from its single California facility.
Summary of the business section of Bio Essence's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Bio Essence Corp
- Founded
- 2000
- Headquarters
- Irvine, CA
- Address
- 2955 Main Street, Ste 300 92614
- Phone
- (888) 816-1494
- Website
- bioessencecorp.com
- Employees
- 4, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- California
- Fiscal year ends
- December 31
- Auditor
- Simon & Edward, LLP, Rowland Heights, CA
Stock & identifiers
- Ticker
- BIOE
- Exchange
- OTC
- Shares outstanding
- 54M, Aug 14, 2026
- Public float
- $26.84M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 1723059
- EIN
- 94-3349551
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yin Yan | Chief Executive Officer, Director | 82,124 |
Employees
Headcount reported in annual reports
“The Company currently has 4 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 14, 2024 | Late filing | Notification of late filing |
| Aug 9, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 5, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| May 15, 2024 | Late filing | Notification of late filing |
| Mar 27, 2024 | Late filing | Notification of late filing |
| May 13, 2022 | Late filing | Notification of late filing |
| Apr 13, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 25, 2021 | Late filing | Notification of late filing |